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SUMMARY
The sense of smell has a high impact on the quality of life. The aim of the present  study was to investigate olfactory dysfunction in patients 
with obstructive sleep apnoea syndrome (OSAS) and correlate the severity of disease with olfactory dysfunction. The relationships between 
nasal obstruction, nasal mucociliary cleareance and olfactory tests were also evaluated. Sixty patients with a diagnosis of OSAS were en-
rolled and underwent olfactory function evaluation.  In all patients olfactory performance was tested with the Sniffin’ Sticks method. Muco-
ciliary transport times and anterior rhinomanometry were performed to identify eventual nasal obstruction and deficits in nasal mucociliary 
clearance. Olfactory dysfunction was present in 22 (36.6%) patients of the study group: of these, hyposmia was present in 19 (86.4%) and 
anosmia in 3 (13.6%). The mean TDI score in the study group was 30. A strong correlation between the olfactory dysfunction and severity 
of sleep apnoea measured using the AHI was found. Patients with OSA would seem to have a high incidence of olfactory dysfunction. The 
degree of olfactory dysfunction appears to be related to the severity of disease. However, other co-factors such as nasal obstruction and 
reduced mucociliary clearance might also play a role in of the aetiology of this condition.
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RIASSUNTO 
Il senso dell’olfatto ha un alto impatto sulla qualità della vita. Lo scopo di questo studio è stato quello di investigare la disfunzione olfattiva 
in pazienti con sindrome delle apnee ostruttive del sonno (OSA) e correlare la gravità della malattia con la perdita di olfatto. Inoltre, è 
stata valutata la relazione esistente tra ostruzione nasale, cleareance mucociliare nasale e i risultati dei test olfattivi. Sessanta pazienti con 
diagnosi di OSA sono stati arruolati in questo studio e hanno eseguito una  valutazione olfattiva. In tutti i pazienti la valutazione olfattiva 
è stata eseguita attraverso lo Sniffin’ Sticks test. Il tempo di trasporto mucociliare e una rinomanometria anteriore sono stati eseguiti per 
identificare una possibile ostruzione nasale e un deficit nella cleareance mucociliare. Una disfunzione olfattiva era presente in 22 (36,6%) 
pazienti dello studio. In questi pazienti con disfunzione olfattiva l’iposmia era presente in 19 (86,4%) casi e l’anosmia in 3 (13,6%) casi. 
Il TDI medio del gruppo di studio presentava uno score di 30. Si è riscontrata una correlazione statistica tra la disfunzione olfattiva e la 
severità delle apnee notture misurata con AHI. I pazienti con OSA sembrerebbero avere un’alta incidenza di disfunzione olfattiva. Il grado 
di disfunzione olfattiva sembrerebbe essere correlato alla gravità della malattia. Tuttavia, altri fattori come una ostruzione nasale e una 
ridotta cleareance mucociliare sembrerebbero avere un ruolo nell’eziologia di questa condizione.
PAROLE CHIAVE: Sindrome delle apnee ostruttive del sonno • Disfunzione olfattiva • Sniffin’ Sticks • Cleareance mucociliare nasale • 
Rinomanometria anteriore
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Introduction
Obstructive sleep apnoea syndrome (OSAS) is a condi-
tion characterised by pauses in breathing and episodes of 
reduction (hypopnea) or absence (apnea) of airflow in the 
upper airways during sleep 1-4. OSAS is becoming more 
commonly recognised because of its significant negative 
effects on daily life and its association with neurocogni-
tive and psychological problems, such as memory and 
new learning, attention, executive function and depres-
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sion 1 5 6. According to the study published by Heinzer et 
al. 7 the incidence of moderate-to-severe sleep-disordered 
breathing (≥ 15 events per hour) is 23.4% in women and 
49.7% in men. 
The sense of smell is a sensorineural system with a high 
impact on the quality of life  8-10. Data regarding the inci-
dence of olfactory dysfunctions in the healthy population 
vary between 10% and 46% of the healthy population 10-15. 
A recent study of a large population showed that the overall 
incidence of olfactory dysfunction was 19.1%, consisting 
of 13.3% and 5.8% of patients with hyposmia and anosmia, 
respectively 16. Similar data were reported by Hummel et 
al. 11 with a 20% incidence of olfactory dysfunction in sub-
jects between 36 and 55 years of age.
Sinonasal diseases, nasal obstruction, head trauma and 
central nervous system disorders that affect neurocogni-
tive functions, drugs, and toxins are the most important 
causes of olfactory dysfunction (OD) 10 15 18 19. The condi-
tions listed above may be variously present in OSAS pa-
tients, making these subjects more inclined to developing 
an olfactory dysfunction 1-4 20-22. 
To our knowledge, only a few authors have evaluated ol-
factory dysfunction in OSAS patients 23-25 and there is a 
scarcity of data concerning the relationship between clini-
cal findings and OD in the medical literature.
The aim of the present study was to investigate: 1) incidence 
of olfactory dysfunction in OSAS patients; 2) correlation 
between the severity of OSAS and OD; 3) relationships be-
tween nasal obstruction, nasal mucociliary clearance and 
olfactory test results in patients with OSAS.
Materials and methods
This prospective study was performed at the of Organi 
di Senso Department (Sleep Disorders Unit) of Sapi-
enza University in Rome between January 2016 and 
February 2017.
The participants were selected from patients who were 
referred to us with a clinical suspicion of sleep apnoea 
syndrome. Initially, clinical data, including height and 
weight, in order to calculate body mass index (BMI), 
medical history, tobacco use and a list of current medica-
tions were collected for each patient. 
Subsequently, each patient was submitted to an ENT physi-
cal examination with nasal endoscopy (2.7  mm  0° rigid 
endoscope) to evaluate the features of nasal structures and 
detect any rhino-sinusal pathologies. 
The exclusion criteria for this study included patients with 
a history of upper respiratory infections within the previ-
ous 3 weeks, sinonasal disorders (nasal polyps, chronic 
rhinosinusitis, allergic rhinitis), asthma, malignancy, head 
trauma, neurological and psychiatric disorders, metabolic 
and endocrine disorders, or a recent history of smoking 
more than 3 cigarettes per day. 
Patients who underwent sleep surgery or currently using 
continuous positive airway pressure were not included in 
the study.
All patients selected for the study had previously under-
gone a polysomnographic (PSG) study to confirm diagno-
sis of OSAS and assess its severity. 
All parameters, sleep stage scoring and event scoring 
were evaluated in accordance with the AASM Manual for 
the Scoring of Sleep and Associated Events 26.
Diagnosis of OSAS was confirmed when the number of 
obstructive events (apnoeas, hypopneas  +  respiratory 
event related arousals) on PSG were  >  15 events/hour 
or > 5/hour in patients reporting typical symptomatology 
(unintentional sleep episodes during wakefulness; day-
time sleepiness; unrefreshing sleep; fatigue; insomnia; 
waking up holding breath, gasping or choking; or loud 
snoring, breathing interruptions or both during the pa-
tient’s sleep as described by the bed partner) 26 27.
In accordance with American Academy of Sleep Medi-
cine (AASM) guidelines, OSAS severity was classified 
on the basis of the apnoea + hypopnoea index (AHI). The 
grade of OSAS was classified as normal (AHI < 5/h), mild 
(AHI ≥ 5 and < 15 plus typical symptomatology), moder-
ate (AHI ≥ 15 and < 30) or severe (AHI ≥ 30) 26 27.
Once the exclusion criteria was applied, 60 patients with a 
PSG diagnosis of OSAS were enrolled in the study. Dur-
ing enrollment of these patients, 20 subjects were selected 
from each OSA category (mild, moderate, severe) to form 
three homogeneous groups for better comparison of olfac-
tory results.
The same exclusion criteria adopted for the study group 
were applied for selection of a control group of patients 
without OSAS. In all the patients of the control group the 
typical symptomatology of OSAS patients was excluded 
and the results of PSG examination showed AHI < 5. For-
ty volunteer subjects were enrolled in this control group.
All OSAS patients enrolled in the study group underwent 
evaluation of olfactory function. Anterior rhinomanom-
etry and mucociliary transport time were performed to 
evaluate nasal obstruction and mucociliary clearance. The 
same study protocol was adopted for the control group.
The study was performed in accordance with the princi-
ples of the Declaration of Helsinki and approved by the 
local Ethics Committee of the University Sapienza of 
Rome. 
All patients gave written informed consent for the PSG, 
olfactory test, rhinomanometry and saccharin test.
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Evaluation of olfactory function
Olfactory performance was tested with the Sniffin’ Sticks 
(Burghart, Wedel, Germany) method  28-30. This test in-
cludes 3 sub-tests that evaluate the olfactory threshold 
(OD), olfactory discrimination (ODs) and identification 
(OI). The sum of the results from each of three differ-
ent sub-tests results in a total score defined as TDI. In 
the analysis of Sniffin’ Sticks tests, the results of the 
TDI score indicated hyposmia when the total TDI score 
was < 30.5, anosmia when < 16.5 and no OD when the 
TDI score was > 30.5 28-30.
Rhinomanometry
Nasal resistance was evaluated in both OSAS patients 
and in the control group using anterior rhinomanometry. 
It has been reported in the literature that the mean total 
resistance in normal subjects ranges between 0.15 and 
0.3 Pa/cm3/s 31. For this reason, total nasal airway resist-
ance > 0.3 Pa/cm3/s was considered pathological.
Mucociliary transport time
Mucociliary transport times were evaluated to identify 
possible deficits of nasal mucociliary clearance. Mucocil-
iary transport time was evaluated in each patient using the 
saccharin test, which is a very simple, quick, non-invasive 
and reproducible method 32 33. About 2.5 mg of granulat-
ed saccharin was placed 1  cm posterior and inferior to 
the head of the inferior turbinate with patients placed in 
the sitting position with the head bent forward. Patients 
were instructed to swallow every 30 seconds and not to 
sniff, sneeze or wipe their noses until they tasted the sac-
charin. The time from placement to perception of sweet 
taste was recorded as the nasal mucociliary clearance time 
(NMCT) 32 33. The same test was performed in OSAS pa-
tients and the study group.
Statistical analysis 
For comparison of data between groups, the chi-square, 
Student’s T test and regression analysis were performed us-
ing XLSTAT software (Addinsoft, 2015). A p value < 0.05 
was considered as statistically significant.
Results 
The characteristics of the 60 patients of the study group 
are summarised in Table I.
Regarding the 60 patients of the study group, 38 were 
male and 22 were female, with an average age of 53.1 
years (range 32-77). The average age of the three sub-
groups was 51.8, 54.5 and 53.4 in the mild, moderate and 
severe OSA subgroups respectively. The average age of 
the control group was 48.4 years. No difference emerged 
regarding mean patient age between the study and control 
groups (p = 0.1). Moreover, no differences were seen in 
mean age between the OSA subgroups (p > 0.05 for all).
Olfactory evaluation
Olfactory dysfunction was present in 22 (36.6%) patients 
of the study group. Of these, hyposmia was present in 
19 (86.4%) cases and anosmia in 3 (13.6%) cases. In the 
control group, 7 (17.5%) patients showed olfactory dys-
function. There was a statistically difference between the 
study and control groups (p = 0.04). 
The mean TDI score of the study group was 30 
(S.D. = 8.09; Hi = 39.0; Low = 12.0),whereas the mean 
TDI score in the control group was 33.3 (S.D.  =  5.31; 
Hi = 39.0; Low = 14.0) with a significant difference be-
tween groups (p = 0.03). 
Regarding olfactory data, it was interesting to note that 
50% of patients with a diagnosis of olfactory dysfunction 
has severe OSAS. In addition, all 3 patients with a diag-
nosis of anosmia belonged to this subgroup. 
Table I. Clinical characteristics of the study group.
OSAS group
N = 60 
Control group
N = 40 
Middle age Total group: 53.1 years; range: 32-76 years 
Mild OSAS: 51.8
Moderate OSAS:54.5
Severe OSAS: 53.4
48.4 years 
Sex 38 Male
22 Female
26 Male
14 Female
BMI (mean) 31.1
OSAS severity Mild OSAS:  20 pts (mean AHI = 10.6)
Moderate OSAS:  20 pts (mean AHI = 20.7)
Severe OSAS:  20 pts (mean AHI = 38.9.)
No OSAS
Mean AHI = 3.9
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The data regarding the distribution of olfactory dys-
function according to OSAS severity is summarised in 
Figure  1. A significant difference (p  =  0.04) in olfac-
tory dysfunction emerged only between mild and severe 
OSAS patients. 
A strong correlation (regression analysis; p  =  0.04; 
R2 = 0.05) between the olfactory dysfunction (TDI) and 
the severity of sleep apnoea using the AHI was found 
(Fig. 2).
Regression analysis between BMI and TDI did not show 
any correlation between high BMI and lower TMC 
scores (p  =  0.07; R2  =  0.06). Moreover, no correlation 
was present between TDI score and middle age (p = 0.7; 
R2 = 0.002).
Rhinomanometry
Thirty-seven patients (61.6%) presented pathological 
bilateral values of nasal airway resistance at rhinomanometric 
examination. No differences regarding rhinomanometry 
results emerged for the different subclasses of OSAS 
patients. Nine patients (22.5%) showed pathological values 
in the control group. 
The difference in the incidence of pathological rhinoma-
nometry between the study and control group was signifi-
cant (p = 0.0002).
Mucociliary transport time 
The mean value of NMCT in OSAS patients was 13.2 min 
(S.D. = 3.13; Hi = 20.0; Low = 7.00; Median = 14.0). On 
the other hand, in the control group a lower NMCT mean 
value (Hi = 15 min; Low = 5 min) of 9.8 min was found. 
The difference between the two groups was statistically 
significant (p = 0.0001).
TDI score, rhinomanometry and mucociliary  
transport time
Comparing the results regarding nasal obstruction and 
olfactory evaluation (Table II): 86.3% of OSAS patients 
with olfactory dysfunction presented a pathological rhi-
Fig. 1. Distribution of patients with olfactory dysfunction according to the OSAS subgroups.
Fig. 2. Linear regression between olfactory TDI and OSAS severity (AHI): TDI 
had a significant and strong correlation with AHI (p = 0.001). 
G. Magliulo et al.
342
nomanometry outcome. There was a significant difference 
between patients with and without olfactory dysfunction 
in terms of rhinomanometry results (p = 0.003) This data 
might indicate that nasal obstruction is correlated to OS-
AS in patients with OD.
The average mucociliary transport time in patients with 
OD was greater than the mean value of OSAS patients 
without OD (14.7  min vs 12.4  min). A significant dif-
ference between these two groups was seen (p = 0.005). 
Moreover, regression analysis between the TDI score and 
NMTC showed a significant correlation (p = 0.008) be-
tween increase of the NMTC and lower values of the TDI 
score (Fig. 3).
Discussion
The available data regarding the incidence and charac-
teristics of olfactory dysfunctions in OSA patients are 
scarce 23-25. Salihoglu et al. 23 in a clinical study regarding 
the effects of obstructive sleep apnoea on olfactory func-
tions demonstrated that OSAS has significant negative 
effects on olfactory capacity, especially on threshold val-
ues and discrimination. Recently, Günbey et al. 24 in an-
other clinical study regarding olfactory function in OSA 
patients, confirmed that patients with severe OSAS had 
scarce total odour scores with respect to non-snorers. 
In accordance with these previous studies, we found that 
olfactory function declined in patients with OSAS. Olfac-
tory dysfunction was present in 22 (36.6%) patients in 
our clinical study. Hyposmia and anosmia were present in 
86.4% and 13.6% of OSAS patients with OD respectively, 
indicating that hyposmia is the most common olfactory 
disorder affecting these patients.
The mean TDI score of the study group was 30 with a 
statistically significant difference between OSAS patients 
and the control group. In addition, our data regarding to-
tal TDI scores and their values in OSAS subclasses (Ta-
ble II) appeared similar to those reported by Salihoglu et 
al. 23 with mean values of 33.4 ± 1.4 in mild and moderate 
OSAS and 31.6 ± 0.9 in severe OSAS.
In our study, 50% of patients with a diagnosis of olfactory 
dysfunction had severe OSAS. A strong negative corre-
lation emerged between the olfactory TDI score and the 
severity of the OSAS measured according to the apnoea–
hypopnoea index (AHI). A negative correlation between 
the olfactory parameters and the severity of sleep apnoea 
was also found in the study by Salihoglu et al. 23.
Regarding BMI values and olfactory function in the study 
by Günbey et al.  24, no significant differences emerged 
in terms of odour parameters, when the subjects were 
evaluated as obese (BMI  ≥  28  kg/m2) and non-obese 
(BMI < 28 kg/m2). Furthermore, Salihoglu et al. 23 did not 
observe any significant effect of BMI on the sum score 
of the Sniffin’ Sticks subtests. The data observed in our 
study would seem to confirm this aspect. 
Olfactory functions are generally negatively associated 
with age and tend to deteriorate further in the elderly 33-35. 
Fig. 3. Linear regression between olfactory TDI and nasal mucociliary 
clearance time: TDI had a significant and strong correlation with nasal muco-
ciliary clearance time (p = 0.008).
Table II. TDI score, rhinomanometry and mucociliary transport time of the study group divided according to the presence or absence of an olfactory dys-
function.
Middle 
age
P-value Pathological 
rhinomanometry
Normal 
rhinomanometry
P-value Mucociliary transport 
time (min)
P-value
OSAS with olfactory 
dysfunction
(N = 22)
52.8 
years p = 0.9 19 (86.3%) 3 (13.7%) p = 0.003 14.7 p = 0.005
OSAS without 
olfactory 
dysfunction 
(N = 38)
53.2 
years
18 (47.3%) 20 (52.7%) 12.4
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In our study, OSAS patients with OD did not have a higher 
mean age than those without OD (Table  III). Regression 
analysis between TDI score and middle age did not iden-
tify any significant correlation (p = 0.7). This aspect would 
seem exclude age as a factor influencing olfactory results 
in OSAS patients. Moreover, no significant difference in 
mean age between the study group and control group was 
observed.
The olfactory epithelium is the first odour identification 
site. Odourants carried by the air enter into the nasal cav-
ity and usually reach the olfactory mucosa through airflow. 
Subsequently, odourants dissolve within the surface of the 
olfactory mucosa and then bind to olfactory receptors in the 
surface of olfactory mucosa, producing nerve impulses 10 19. 
In our opinion, especially in OSA patients, two impor-
tant aspects related to the transport of odourants at the 
olfactory epithelium, should be analysed and discussed. 
These are possible nasal obstruction and nasal mucocili-
ary clearance.
Patients with OSA most often present concurrent nasal 
obstruction 21 22. The latter has been implicated as an inde-
pendent, aetiological factor in the pathogenesis of OSA, 
although no definite conclusions on the role of nasal ob-
struction in OSA pathogenesis have been reported 21 22. It 
would seem that nasal obstruction results in an increase 
in upstream airflow resistance, which makes the pharynx 
vulnerable to collapse. During sleep, breathing is primar-
ily nasal, but patients with nasal airway obstructions fa-
vour oral breathing, which decreases the hypopharyngeal 
space, leading to increased upper airway resistance and 
more frequent apnoeic and hypopnoeic episodes 36-39.
Clearly, nasal obstruction is frequently associated with 
OD because it results in a reduction of the number of 
odourants that enter the nose during breathing 17 38. Only 
Fu et al. 25 reported a relationship between nasal structure 
and olfactory function in patients with obstructive sleep 
apnoea. They investigated OSAS patients using acoustic 
rhinometry and found a correlation between nasal ob-
struction and lower TDI score. Based on these data they 
suggested that nasal structure affects parameters of olfac-
tory function, probably via alterations in nasal airflow.
In our study, we preferred to measure nasal air-flow di-
rectly via an anterior rhinomanometry. The OSAS patients 
in our study showed pathological bilateral values of nasal 
airway resistance in 61.6% of cases. Moreover, 86.3% of 
OSAS patients with olfactory dysfunction presented path-
ological rhinomanometry values. In our study, there was 
a significant difference between patients with and without 
olfactory dysfunction regarding rhinomanometry results, 
indicating that nasal obstruction could be a cofactor that is 
responsible for OD in these patients (Table III).
Inflammation of the nasal mucosa with alterations in nasal 
mucociliary clearance are a frequent cause of olfactory neu-
roepithelium dysfunction. Usually, poor mucociliary clear-
ance hinders the interaction between odourous molecules 
contained in inspired air and the olfactory epithelium 16 37-40.
Most OSAS patients present a reduced mucosal clearance 
even in the absence of evident sinonasal inflammatory 
diseases  39-43. In a recent clinical study regarding nasal 
mucociliary clearance in obstructive sleep apneoa syn-
drome patients, Deniz et al. 44 demonstrated that the nasal 
mucociliary system presents significant deterioration in 
severe OSAS patients. 
The mean value of NMCT in the OSAS patients of our 
study was 13.2 min with a significant difference vs to the 
control group. 
It is interesting to note that the mean mucociliary transport 
time in OSAS patients with OD was greater than the mean 
NMCT value of the OSAS patients without OD (14.7 min 
vs 12.4 min). A statistically significant difference between 
these two groups emerged. Furthermore, regression anal-
ysis between TDI score and NMTC showed a significant 
correlation between the increase of the NMTC and lower 
values of the TDI score (Fig. 3). These findings could indi-
cate that reduced mucociliary clearance represents another 
cofactor in the OD aetiology of OSAS patients. 
Table III. OSAS group vs control group: olfactory evaluation, rhinomanometry and mucociliary transport time.
OSAS group
N = 60 
Control group
N = 40 
P-value
Olfactory dysfunction:
Hyposmia 
Anosmia
22 (36.6%)
19 (86.4%)
3 (13.6%)
7 (17.5%)
6 (85.7%)
1 (14.3%)
0.04
TDI score (mean value)
Mild OSAS
Moderate OSAS
Severe OSAS
30 
33
30.7
26.2
33.3 0.03
Rhinomanometric examination 37 61.6%) 9 (22.5%) 0.0002
NMCT (mean value) 13.2 min 9.8 min 0.0001
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Gastro-oesophageal reflux disease (GERD) or laryn-
gopharyngeal reflux disease (LPRD) may be comorbidi-
ties in patients with OSAS and an alteration of taste, due 
to acid aggression, might be possible in these patients 45-48. 
However, such conditions do not seem to alter the results 
of mucociliary transport time measured using the saccharin 
test, because as reported by Altundag et al., no impairment 
in sweet taste is present in OSAS patients with LPRD 47 48.
To avoid reflux and other possible subjective interfer-
ences, a composition of vegetable charcoal powder and 
saccharin powder at 3% could be used in alternative to the 
traditional saccharin test 49.
Finally, regarding the aetiopathogenetic factors of OD in 
OSAS patients, it should be remembered that intermittent 
nocturnal hypoxia/reoxygenation episodes represent a 
trigger for upper airway inflammation and the increase of 
pro-inflammatory markers such as interleukin-8, tumour 
necrosis factor-α, or C-reactive protein  40 50 51. It is pos-
sible that these inflammatory mediators might contribute 
to the harmful effects on olfactory neuroepithelium that 
occur in these patients. An extensive study through evalu-
ation of inflammatory mediators (e.g. cytokines, interleu-
kins, chemokines, TNF etc.) and nasal cytological aspects 
is under way in order to broaden current knowledge about 
olfactory damage in patients with sleep apnoea syndrome.
Conclusions
Patients with OSAS appear to suffer from olfactory dys-
function more than adults who are not affected by sleep 
apnoea syndrome. The degree of olfactory dysfunction 
appears to be related to severity of disease. However, 
other factors such as nasal obstruction and reduced mu-
cociliary clearance play a role in of the aetiology of this 
condition.
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